Henry ScheinHSICEarnings & Financial Report
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world’s largest provider of health care solutions to office-based dental and medical practitioners. For 14 consecutive years, the company has been named as one of the World's Most Ethical Companies by Ethisphere, most recently in 2025.
HSIC Q3 2025 Key Financial Metrics
売上高
$3.3B
粗利益
$1.0B
営業利益
$164.0M
純利益
$101.0M
粗利益率
30.7%
営業利益率
4.9%
純利益率
3.0%
前年比成長
5.2%
EPS
$0.84
資金フロー
Henry Schein Q3 2025 Financial Summary
Henry Schein reported revenue of $3.3B for Q3 2025, with a net profit of $101.0M (3.0% margin). Cost of goods sold was $2.3B, operating expenses totaled $862.0M.
Key Financial Metrics
| Total Revenue | $3.3B |
|---|---|
| Net Profit | $101.0M |
| Gross Margin | 30.7% |
| Operating Margin | 4.9% |
| Report Period | Q3 2025 |
Henry Schein Annual Revenue by Year
Henry Schein annual revenue history includes year-by-year totals (for example, 2024 revenue was $12.7B).
| Year | Annual Revenue |
|---|---|
| 2024 | $12.7B |
| 2023 | $12.2B |
| 2022 | $12.6B |
損益計算書
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $3.02B | $3.17B | $3.14B | $3.17B | $3.19B | $3.17B | $3.24B | $3.34B |
| 前年比成長 | -10.5% | N/A | 2.5% | 2.4% | N/A | -0.1% | 3.3% | 5.2% |
貸借対照表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $10.57B | $10.14B | $10.25B | $10.61B | $10.22B | $10.48B | $10.91B | $11.10B |
| 総負債 | $5.42B | $5.11B | $5.25B | $5.63B | $5.38B | $5.76B | $6.01B | $6.20B |
| 株主資本 | $3.65B | $3.60B | $3.51B | $3.50B | $3.39B | $3.31B | $3.44B | $3.36B |
キャッシュフロー
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $-32.0M | $197.0M | $296.0M | $151.0M | $204.0M | $37.0M | $120.0M | $174.0M |
Other Health Care Companies
CAH
Cardinal Health
売上高
$65.6B
純利益
$467.0M
COR
Cencora
売上高
$85.9B
純利益
$559.6M
MCK
McKesson Corporation
売上高
$106.2B
純利益
$1.2B
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B
BAX
Baxter International
売上高
$3.0B
純利益
$-1.1B
BDX
Becton Dickinson
売上高
$5.3B
純利益
$382.0M